Biological products, (no disgnostic substances) Sample Contracts
EMPLOYMENT AGREEMENT DATE: December 17, 2004 PARTIES: Techne Corporation, a Minnesota corporation 614 McKinley Place N.E. Minneapolis, Minnesota 55413 Gregory J. Melsen AGREEMENTS: ARTICLE 1. TERM OF EMPLOYMENT: DUTIES AND SUPERVISION 1.1) Parties....Employment Agreement • December 20th, 2004 • Techne Corp /Mn/ • Biological products, (no disgnostic substances) • Minnesota
RECITALSRegistration Rights Agreement • April 4th, 2006 • Brainstorm Cell Therapeutics Inc • Biological products, (no disgnostic substances) • New York
EXHIBIT 99.2 Published CUSIP Number: [________________] CREDIT AGREEMENT Dated as of June 29, 2007Credit Agreement • July 2nd, 2007 • Biogen Idec Inc. • Biological products, (no disgnostic substances) • New York
BackgroundEmployment Agreement • November 15th, 2002 • Integra Lifesciences Holdings Corp • Biological products, (no disgnostic substances) • New Jersey
EXHIBIT 10.42 HESKA CORPORATION STOCK PURCHASE AGREEMENT This STOCK PURCHASE AGREEMENT (this "Agreement"), is made and entered into as of February 1, 2001, by and among HESKA CORPORATION, a Delaware corporation (the "Company"), and the purchasers...Stock Purchase Agreement • February 7th, 2001 • Heska Corp • Biological products, (no disgnostic substances) • Delaware
as Issuer andIndenture • May 25th, 2006 • Enzon Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
AMGEN INC.Distribution Agreement • December 9th, 1997 • Amgen Inc • Biological products, (no disgnostic substances) • New York
GENZYME GENZYME TRANSGENICS CORP. TRANSGENICS 175 CROSSING BOULEVARD, SUITE 410 PO. BOX 9322 FRAMINGHAM, MA 01701-9322 TEL 508-620-9700 FAX 508-370-3797 MANAGEMENT AGREEMENT This Severance Agreement, dated as of June 14, 2000, is among Genzyme...Severance Agreement • May 6th, 2003 • GTC Biotherapeutics Inc • Biological products, (no disgnostic substances) • Massachusetts
LEASELease Agreement • March 28th, 2003 • Zymogenetics Inc • Biological products, (no disgnostic substances) • Washington
Exhibit 10.12 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement") is entered into as of the first day of November, 2004, by and between Daniel J. Kerkman ("Employee"), and APPLIED NEUROSOLUTIONS, INC. ("APNS"), a Delaware corporation...Employment Agreement • March 25th, 2005 • Applied Neurosolutions Inc • Biological products, (no disgnostic substances) • Illinois
Exhibit 10.3 CONSULTING AGREEMENT This Consulting Agreement ("Agreement") is being entered into as of this 12th day of July, 2005, between APPLIED DNA SCIENCES, INC., a Nevada corporation (the "Company"), with offices at 9229 West Sunset Bvd, Suite...Consulting Agreement • July 21st, 2005 • Applied Dna Sciences Inc • Biological products, (no disgnostic substances) • California
Exhibit 10.36 CREDIT AGREEMENT AMONG GENZYME CORPORATION, THE SUBSIDIARY GUARANTORS PARTY HERETO, THE LENDERS PARTY HERETO, AND FLEET NATIONAL BANK, AS ADMINISTRATIVE AGENT, ABN AMRO BANK N.V., AS SYNDICATION AGENT AND THE BANK OF NOVA SCOTIA,...Credit Agreement • March 15th, 2004 • Genzyme Corp • Biological products, (no disgnostic substances) • Massachusetts
BACKGROUNDEscrow Agreement • November 15th, 2004 • Mymetics Corp • Biological products, (no disgnostic substances) • Delaware
RECITALSPurchase Agreement • February 13th, 2004 • Hemoxymed Inc • Biological products, (no disgnostic substances) • New York
WARRANTWarrant Agreement • June 17th, 2008 • Microislet Inc • Biological products, (no disgnostic substances) • New York
FORM OF COMMON STOCK PURCHASE WARRANTSecurity Agreement • January 16th, 2025 • Outlook Therapeutics, Inc. • Biological products, (no disgnostic substances)
This Warrant is one of a series of similar warrants issued pursuant to those certain letter agreements, dated January 16, 2025, by and among the Company and each warrantholder identified therein (each, a “Letter Agreement”). All such warrants are referred to herein, collectively, as the “Warrants.”
ARTICLE IVoting Agreement • April 1st, 2003 • Aphton Corp • Biological products, (no disgnostic substances) • New York
Pledgor has, on this date, executed and delivered to Pledgees or their assigns a promissory note dated the date hereof in the principal amount of Two Hundred Seventy Nine Million Four Hundred Seventeen Thousand and Nine Hundred Eighty- two Dollars...Pledge Agreement • January 18th, 2002 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • New York
ANDManagement Agreement • September 8th, 2003 • Zein Youssef El • Biological products, (no disgnostic substances) • Isle of Man
AS ISSUER,First Supplemental Indenture • March 27th, 2002 • Charles River Laboratories International Inc • Biological products, (no disgnostic substances) • New York
COMMON STOCK PURCHASE WARRANT CURIS, INC.Common Stock Purchase Warrant • March 28th, 2025 • Curis Inc • Biological products, (no disgnostic substances) • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_____________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Requisite Stockholder Approval Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on March [__], 2030 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Curis, Inc., a Delaware corporation (the “Company”), up to [_________] shares (as subject to adjustment hereunder, the “Warrant Shares”) of common stock, par value $0.01 per share, of the Company (“Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Exhibit 10.20 BIOSANTE PHARMACEUTICALS, INC. SUBSCRIPTION AGREEMENT BioSante Pharmaceuticals, Inc. 175 Olde Half Day Road, Suite 247 Lincolnshire, IL 60069 Attn: Mr. Stephen M. Simes Ladies and Gentlemen: 1. SUBSCRIPTION. The undersigned is hereby...Subscription Agreement • June 29th, 2001 • Biosante Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Illinois
Exhibit 10.1 MICROISLET, INC. A NEVADA CORPORATION STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT (this "Agreement") dated as of August 28, 2003 is entered into between MicroIslet, Inc., a Nevada corporation (the "Company") and Investment...Stock Purchase Agreement • September 11th, 2003 • Microislet Inc • Biological products, (no disgnostic substances) • California
EXECUTION COPYLoan and Security Agreement • March 22nd, 2002 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Massachusetts
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 6th, 2025 • Cero Therapeutics Holdings, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of February 5, 2025, between CERo Therapeutics Holdings, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
EXHIBIT 10.13 EMPLOYMENT AGREEMENT THIS AGREEMENT, made effective as of this 1st day of January, 2003, by and between STEVEN A. GOULD, M.D. ("Employee") and NORTHFIELD LABORATORIES INC., a Delaware corporation (the "Company"). W I T N E S S E T H : -...Employment Agreement • June 27th, 2003 • Northfield Laboratories Inc /De/ • Biological products, (no disgnostic substances) • Illinois
EXHIBIT 4.1 NOTE PURCHASE AGREEMENT This Note Purchase Agreement (this "Agreement") is made as of April 23, 2004 (the "Closing Date") by and between Ceptor Corporation, a Delaware corporation (the "Company"), and the persons or entities listed as...Note Purchase Agreement • May 28th, 2004 • Xechem International Inc • Biological products, (no disgnostic substances) • Delaware
WARRANTWarrant Agreement • March 21st, 2008 • Microislet Inc • Biological products, (no disgnostic substances) • New York
EXHIBIT 10.2 DISTRIBUTION AGREEMENTDistribution Agreement • May 14th, 2003 • Senetek PLC /Eng/ • Biological products, (no disgnostic substances)
Exhibit 10.13 BRAINSTORM CELL THERAPEUTICS INC. OPTION AGREEMENT Made effective as of the 31st day of December, 2004 BETWEEN: Brainstorm Cell Therapeutics Inc. A company incorporated in Washington (hereinafter the "Company")Option Agreement • April 1st, 2005 • Brainstorm Cell Therapeutics Inc • Biological products, (no disgnostic substances)
BY AND AMONG AMGEN INC.,Merger Agreement • December 17th, 2001 • Amgen Inc • Biological products, (no disgnostic substances) • Delaware
BY AND AMONGMerger Agreement • May 2nd, 2005 • Corixa Corp • Biological products, (no disgnostic substances) • Delaware
Common Stock ($.01 Par Value)Underwriting Agreement • February 4th, 2005 • Northfield Laboratories Inc /De/ • Biological products, (no disgnostic substances) • New York
Exhibit 6 EXECUTION COPY SHARE PURCHASE AGREEMENT Dated as of September 21, 2006Share Purchase Agreement • September 25th, 2006 • Bertarelli Ernesto • Biological products, (no disgnostic substances)
EXHIBIT 10.34 ALFACELL CORPORATION 2004 STOCK INCENTIVE PLAN STOCK OPTION AGREEMENT AGREEMENT, made and entered into on the date set forth on Exhibit A attached hereto ("Exhibit A") by and between Alfacell Corporation (the "Company") and the...Stock Option Agreement • March 12th, 2007 • Alfacell Corp • Biological products, (no disgnostic substances) • New Jersey